Refine by
Sinusitis Articles & Analysis
25 news found
Infective CR is usually caused by sinusitis, whereas 48% of noninfective CR (NICR) is allergic (ACR), 15% nonallergic eosinophilic (NAECR), and 37% vasomotor (VMCR) in origin.2 The estimated incidence of allergic rhinitis in the United States is 24 million.3 One quarter of these cases are chronic,4 which implies that approximately one person in every four households has NICR. ...
Ondine’s photodisinfection is a platform technology under development for a wide variety of conditions including presurgical decolonisation, and treatment of burns, wounds, ventilator-associated pneumonia, and chronic sinusitis. “The rising rates of COVID-19 due to rapidly evolving SARS-CoV-2 variants underline the importance of our broad-spectrum nasal ...
While photodisinfection is initially focussed on preventing HAIs, the technology can be used widely to kill pathogens in many applications such as burns, ulcers, sinusitis, skin infections — anywhere the photosensitizer liquid can be activated by a specific wavelength of light. ...
CF is a progressive, multi-organ disease that affects the lungs, liver, pancreas, GI tract, sinuses, sweat glands and reproductive tract. CF is caused by a defective and/or missing CFTR protein resulting from certain mutations in the CFTR gene. ...
It can result in IPD, including meningitis and bacteremia, and non-invasive PD, including pneumonia, otitis media and sinusitis. Despite universal vaccination for PD in infants and in many adults in the United States, the overall incidence of PD is substantial and is driven by emerging serotypes not covered by currently available vaccines. ...
It can result in IPD, including meningitis and bacteremia, and non-invasive PD, including pneumonia, otitis media and sinusitis. The global incidence of PD is driven by emerging serotypes not covered by currently available vaccines. ...
Intersect ENT’s PROPEL sinus implants uniquely provide mechanical stenting of a patient’s sinuses while providing localized delivery of the corticosteroid mometasone furoate directly to healing sinus tissue, features that have been shown previously to improve outcomes after sinus surgery.1-3 “As one of the first observational studies to use real-world evidence ...
Lyra has two product candidates in development for CRS, a highly prevalent inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities: LYR-210, for surgically naïve patients, and LYR-220, for patients who have recurrent symptoms despite surgery. ...
It can result in invasive PD (IPD), including meningitis and bacteremia, and non-invasive PD, including pneumonia, otitis media and sinusitis. The global incidence of PD is driven by emerging serotypes not covered by currently available vaccines. ...
FESS is used to treat chronic rhinosinusitis, a persistent inflammation of the sinuses that can be debilitating to patients. Intersect ENT’s PROPEL Contour is a drug-eluting, bioabsorbable sinus implant that is placed in the frontal sinus (between the eyebrows) following sinus surgery. ...
The manuscript titled, “Drug Release and Pharmacokinetic Evaluation of Novel Implantable Mometasone Furoate Matrices in Rabbit Maxillary Sinuses,” can be accessed online here. The pharmacokinetics and drug release study evaluated the release of mometasone furoate (MF), a potent anti-inflammatory corticosteroid formulated into Lyra’s proprietary XTreo™ ...
It is one of the top 10 most costly medical conditions for employers, with most patients reporting 5-15+ years of suffering and medical treatment.1-3 Intersect ENT's PROPEL implant – used primarily in hospitals and ambulatory surgery centers – is a bioabsorbable, drug-eluting implant inserted after sinus surgery to keep passageways open and deliver an anti-inflammatory steroid to the ...
As many as 1 in 8 adults in the United States suffer from CRS, a condition in which the sinuses within the nose and head become swollen and inflamed for three months or longer, causing blockage of airflow and drainage. Over time, the sinuses can become infected leading to inflammation and pain. Up to 60% of CRS patients may not experience significant improvements ...
PROPEL Contour features an innovative hourglass shape, specifically designed for placement in the frontal sinuses (between the eyebrows) following sinus surgery for chronic rhinosinusitis patients. ...
Risks may include, but are not limited to, pain/pressure, displacement of the implant, possible side effects of intranasal MF, sinusitis, epistaxis, and infection. For full prescribing information see IFU at www.IntersectENT.com/technologies/. ...
“We are dedicated to responding to our customers’ feedback and providing them with the best combination of products to advance care for chronic sinusitis patients in various centers of care.” “The combination of the PROPEL Mini and the Straight Delivery System in one package is reflective of Intersect ENT’s ongoing commitment to supporting the ENT ...
But most of us don’t have Chronic Sinusitis, which consists of a sinus infection lasting longer than 3 months (despite treatment), according to the Mayo Clinic. ...
” Repeated application of NORSTM has been demonstrated to be safe and potentially effective in patients with chronic sinusitis. Further trials have demonstrated its effectiveness in-vitro against viruses, including influenza A, hCoV-OC43 and H1N1. ...
The Sinusleeve™ Balloon is a single-use, disposable, balloon sinus dilation device (BSD) used for treating chronic sinusitis. Developed and manufactured in the United States, this patented device fits over rigid, flexible and reusable positioning and suction devices by way of a conforming sleeve. ...
The balloon sinus dilation sleeve will be used by ENT’s in procedures that treat Chronic Sinusitis, a condition which affects up to 30 million people in the United States. ...